Director

Jane as Director of the Translational Research office is responsible for a team of 24 highly experienced industrial translational scientists tasked with establishing the organisational culture, capability and processes necessary to deliver the UCL and BRC’s mission of "Accelerating translation for health and wealth". The TRO supports the development of early stage research from across UCL and its partner hospitals, into projects attractive for translational funding or further development with partners and nurture access to complementary capacity, expertise and skills in translational science. The TRO achieves this through the integrated activities of three specialist groups a Drug Discovery Group (DDG) provides expert advice and practical support for small molecule drug discovery projects across UCL; a Translational Research Group who provide experienced project leaders to guide projects (gene, cell and regenerative medicine therapies, devices, diagnostics, small molecules) through their development; and an Industrial Partnerships Group who initiate and manage relationships with industry. Jane has extensive experience in developing therapies to clinical benefit gained from >20 years working in large pharma and academia. Her experience has spanned the drug discovery pathway from target validation, lead optimisation, candidate selection through to the clinic and to marketing authorisation.